Trial Profile
Biological Half Life of DLBS1033 in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Lumbricus rubellus (Primary)
- Indications Embolism and thrombosis
- Focus Biomarker; Pharmacodynamics
- 11 May 2017 Status changed from recruiting to completed.
- 01 Aug 2013 New trial record